复发性结肠直肠癌与EGFR抑制剂诱导的皮肤病副作用之间的关系:聚焦膜
Omer Esmez1, Merve Yıldız Esmez2, Gulnİhal Deniz3
1Ortopedia and travmatology, Elazığ Fethi Sekin City Hospital, Elâzığ, Turkey dresmezomer@gmail.com.
BMJ case reports
|January 6, 2026
概括
严重的皮肤副作用发生在一个结肠直肠癌患者在panitumumab治疗期间. 及时的支持性护理管理了这些表皮生长因子受体 (EGFR) 抑制剂毒性,允许癌症治疗继续.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 再发性结直肠癌需要有效的治疗策略.
- 皮肤上生长因子受体 (EGFR) 抑制剂,如帕尼图穆马布,用于癌症治疗.
- 皮肤毒性是EGFR抑制剂的常见副作用.
研究的目的:
- 在治疗复发性结肠直肠癌期间报告严重皮肤毒性病例.
- 为了突出EGFR抑制剂诱导的皮肤毒性的管理.
- 强调支持性护理在维持癌症治疗中的重要性.
主要方法:
- 一个40多岁的女性病例报告,患有复发性结肠直肠癌.
- 皮肤学毒性的描述,包括形喷发,化和.
- 多学科,符合指南的支持性护理,包括局部措施和全身治疗.
主要成果:
- 患者出现了严重的形喷发,化和EGFR抑制剂诱导的.
- 支持性护理实现了症状控制.
- 帕尼图穆马布的抗癌治疗成功地继续进行.
结论:
- 早期识别和结构化管理EGFR抑制剂毒性至关重要.
- 有效的支持性护理可以防止治疗中断,并保持生活质量.
- 多学科护理对于管理复杂的癌症治疗副作用至关重要.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Inflammatory Bowel Disease II: Crohn's Disease
945
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
945
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
480
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
564
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
564


